Creating new chemical compounds using acetal radicals
Development of Acetal Radicals in Organic Synthesis
This study is exploring new ways to make important chemical compounds that could help create better medicines and agricultural products, using special techniques to ensure the process is safe and efficient.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10937382 on NIH RePORTER |
What this research studies
This research focuses on developing innovative chemical reagents and methods to create valuable carbonyl compounds from acetal-based radical precursors. By utilizing acetal radicals, the project aims to synthesize a variety of medicinally relevant molecules that can benefit the pharmaceutical and agrochemical industries. The research involves designing novel reagents to prevent unwanted side reactions and employing advanced techniques to construct complex molecular structures efficiently. This work is expected to enhance the capabilities of synthetic medicinal chemistry.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that could be treated by new pharmaceutical agents derived from the synthesized compounds.
Not a fit: Patients who are not affected by conditions treatable with the new compounds being developed may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new drugs and therapeutic agents that improve patient outcomes.
How similar studies have performed: Other research in the field of organic synthesis has shown success in developing new reagents and methods, indicating that this approach has potential for significant advancements.
Where this research is happening
Philadelphia, United States
- Temple Univ of the Commonwealth — Philadelphia, United States (Active)
Researchers
- Principal investigator: Kim, Daniel Kwanwoo — Temple Univ of the Commonwealth
- Study coordinator: Kim, Daniel Kwanwoo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.